These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 27409000

  • 1. Globe Salvage With Intra-Arterial Topotecan-Melphalan Chemotherapy in Children With a Single Eye.
    Leal-Leal CA, Asencio-López L, Higuera-Calleja J, Bernal-Moreno M, Bosch-Canto V, Chávez-Pacheco J, Isaac-Otero G, Beck-Popovic M.
    Rev Invest Clin; 2016; 68(3):137-42. PubMed ID: 27409000
    [Abstract] [Full Text] [Related]

  • 2. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP.
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [Abstract] [Full Text] [Related]

  • 3. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL, Say EA, Pointdujour-Lim R, Cao C, Jabbour PM, Shields JA.
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [Abstract] [Full Text] [Related]

  • 4. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P, Ceciliano A, Millan N, Taich P, Villasante F, Fandino AC, Dominguez J, Chantada GL.
    Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
    [Abstract] [Full Text] [Related]

  • 5. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
    Shields CL, Alset AE, Say EA, Caywood E, Jabbour P, Shields JA.
    J Pediatr Ophthalmol Strabismus; 2016 Sep 01; 53(5):275-84. PubMed ID: 27486728
    [Abstract] [Full Text] [Related]

  • 6. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL, Manjandavida FP, Lally SE, Pieretti G, Arepalli SA, Caywood EH, Jabbour P, Shields JA.
    Ophthalmology; 2014 Jul 01; 121(7):1453-60. PubMed ID: 24656794
    [Abstract] [Full Text] [Related]

  • 7. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
    Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA.
    J Neurosurg; 2011 Jun 01; 114(6):1603-8. PubMed ID: 21294621
    [Abstract] [Full Text] [Related]

  • 8. Clinical pharmacokinetics of intra-arterial melphalan and topotecan combination in patients with retinoblastoma.
    Taich P, Ceciliano A, Buitrago E, Sampor C, Fandino A, Villasante F, Lucena E, Romero L, Chantada GL, Schaiquevich P.
    Ophthalmology; 2014 Apr 01; 121(4):889-97. PubMed ID: 24359624
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective Ophthalmic Artery Infusion Chemotherapy for Advanced Intraocular Retinoblastoma: CCHMC Early Experience.
    Michaels ST, Abruzzo TA, Augsburger JJ, Corrêa ZM, Lane A, Geller JI.
    J Pediatr Hematol Oncol; 2016 Jan 01; 38(1):65-9. PubMed ID: 26583615
    [Abstract] [Full Text] [Related]

  • 11. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP.
    Ophthalmology; 2008 Aug 01; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
    Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH.
    Arch Ophthalmol; 2011 Jun 01; 129(6):732-7. PubMed ID: 21320950
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL, Douglass AM, Beggache M, Say EA, Shields JA.
    Retina; 2016 Jun 01; 36(6):1184-90. PubMed ID: 26630319
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review.
    Ong SJ, Chao AN, Wong HF, Liou KL, Kao LY.
    Jpn J Ophthalmol; 2015 Mar 01; 59(2):109-17. PubMed ID: 25465196
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
    Muen WJ, Kingston JE, Robertson F, Brew S, Sagoo MS, Reddy MA.
    Ophthalmology; 2012 Mar 01; 119(3):611-6. PubMed ID: 22197434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.